239 related articles for article (PubMed ID: 35553375)
21. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
[TBL] [Abstract][Full Text] [Related]
22. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
23. Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer's Disease: Recent Trends and Future Development.
Dave BP; Shah YB; Maheshwari KG; Mansuri KA; Prajapati BS; Postwala HI; Chorawala MR
Cell Mol Neurobiol; 2023 Nov; 43(8):3847-3884. PubMed ID: 37725199
[TBL] [Abstract][Full Text] [Related]
24. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
25. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
26. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
27. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
Ashrafian H; Zadeh EH; Khan RH
Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's Disease Therapeutic Approaches.
Revi M
Adv Exp Med Biol; 2020; 1195():105-116. PubMed ID: 32468465
[TBL] [Abstract][Full Text] [Related]
29. Amyloid-β and Tau at the Crossroads of Alzheimer's Disease.
Gallardo G; Holtzman DM
Adv Exp Med Biol; 2019; 1184():187-203. PubMed ID: 32096039
[TBL] [Abstract][Full Text] [Related]
30. Disease-modifying drugs in Alzheimer's disease.
Ghezzi L; Scarpini E; Galimberti D
Drug Des Devel Ther; 2013 Dec; 7():1471-8. PubMed ID: 24353405
[TBL] [Abstract][Full Text] [Related]
31. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
Cheng XR; Zhou WX; Zhang YX
Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
[TBL] [Abstract][Full Text] [Related]
32. Role of Receptors in Relation to Plaques and Tangles in Alzheimer's Disease Pathology.
Sharma K; Pradhan S; Duffy LK; Yeasmin S; Bhattarai N; Schulte MK
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884789
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer's disease: current status of etiopathogenesis and therapeutic strategies.
Khairallah MI; Kassem LA
Pak J Biol Sci; 2011 Feb; 14(4):257-72. PubMed ID: 21870628
[TBL] [Abstract][Full Text] [Related]
34. [One hundred years of Alzheimer's disease: immunotherapy a hope?].
Behrens P MI; Vergara E F
Rev Med Chil; 2007 Jan; 135(1):103-10. PubMed ID: 17369991
[TBL] [Abstract][Full Text] [Related]
35. Recent update on the heterogeneity of the Alzheimer's disease spectrum.
Jellinger KA
J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
Pinheiro L; Faustino C
Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
[TBL] [Abstract][Full Text] [Related]
37. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
Shukla V; Skuntz S; Pant HC
Arch Med Res; 2012 Nov; 43(8):655-62. PubMed ID: 23142263
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Melatonin and Neurotransmission in Alzheimer's Disease.
Roy J; Tsui KC; Ng J; Fung ML; Lim LW
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202125
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease.
Kumar K; Kumar A; Keegan RM; Deshmukh R
Biomed Pharmacother; 2018 Feb; 98():297-307. PubMed ID: 29274586
[TBL] [Abstract][Full Text] [Related]
40. The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease.
Wilcock DM
CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):386-94. PubMed ID: 20522016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
